Antenatal Steroids are a foundational intervention for women facing threatened preterm birth. This critical medication significantly reduces the risk of respiratory distress syndrome (RDS) and other neonatal complications. Therefore, the way a course of treatment is administered is highly important. A recent observational study highlighted variations in Antenatal Steroids (AS) course durations across different regions and gestational ages. Understanding the adherence to, and deviation from, recommended protocols is vital for improving global neonatal outcomes.
The Goal of Antenatal Steroid Administration
Administering Antenatal Corticosteroids (ACS) to the mother is the most effective strategy for reducing morbidity and mortality in premature babies. The fluorinated glucocorticoid hormones cross the placenta efficiently. Consequently, they trigger the production of surfactant in the fetal lungs. Surfactant allows the baby to establish regular breathing patterns. Additionally, ACS provides protective effects on cerebral blood vessels, thereby reducing the risk of intraventricular hemorrhage (IVH), and on the intestines, which lowers the risk of necrotizing enterocolitis (NEC). A single course of corticosteroids is the general recommendation for pregnant women between 24 weeks and 34 weeks of gestation who are at a high risk of delivering within seven days. Moreover, guidelines emphasize that Betamethasone or Dexamethasone can be used interchangeably, depending on availability.
Optimal Timing for Antenatal Steroids
The core challenge for clinicians is the precise timing of administration. Research indicates the efficacy of Antenatal Steroids is highest when the delivery occurs between two and seven days after the start of therapy. However, this optimal window is frequently missed in clinical practice, often leading to either sub-optimal treatment or unnecessary overtreatment. An observational study found that a majority of women do not give birth within this critical seven-day timeframe following steroid administration. This fact highlights the difficulty in predicting the exact timing of preterm labor. In conclusion, clinicians must carefully consider the probability of imminent preterm birth when deciding to initiate a course.
Addressing Repeat and Shortened Courses
The observational study on shortened AS courses focused on documenting real-world practice variations. Shortened courses may occur because the mother delivers before the full regimen can be completed. However, a significant concern in current practice involves the use of “rescue” or repeat courses. Although rescue courses may be considered under specific, limited circumstances, multiple rescue courses are generally not recommended due to potential long-term harm. Repetitive dosing has been associated with small but significant decrements in both birth weight and head circumference in some studies. Therefore, current international and national guidelines strongly caution against routine repeated administration of Antenatal Steroids. Furthermore, the goal is always to ensure a single, complete course is delivered within the optimal gestational window.
Frequently Asked Questions
Q1: What is the recommended gestational window for Antenatal Steroids?
Antenatal Corticosteroids are generally recommended for women with a high likelihood of preterm birth between 24 weeks and 34 weeks of gestation, especially if delivery is anticipated within the next seven days.
Q2: What is the optimal treatment-to-delivery interval for Antenatal Steroids?
The maximum benefit of the steroids, in terms of reducing neonatal complications, is achieved when delivery occurs between two and seven days after the start of the administration.
Q3: Are multiple or “rescue” courses of Antenatal Steroids recommended?
While a single rescue course may be considered in very specific, high-risk situations (such as if the initial course was given more than 7-14 days prior and the risk remains high), multiple rescue courses are strongly discouraged due to concerns about potential adverse long-term effects on the neonate.
References
- Pettinger K et al. Shortened Courses of Antenatal Steroids in Preterm Births: An Observational Study. BJOG. 2026 Feb undefined. doi: 10.1111/1471-0528.70059. PMID: 41491630.
- Antenatal Corticosteroids Guidelines 2022. Available at: [https://www.scribd.com/document/556708681/Antenatal-Corticosteroids-Guidelines-2022].
- WHO recommendations on antenatal corticosteroid therapy for improving preterm birth outcomes. Available at: [https://www.ncbi.nlm.nih.gov/books/NBK585640/].
- Strategies to improve antenatal corticosteroid usage in woman at risk of preterm labor in India. Available at: [https://journalgrid.com/article-reader/strategies-to-improve-antenatal-corticosteroid-usage-in-woman-at-risk-of-preterm-labor-in-india-2/].